A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase
摘要:
The identification of a proper lead compound for fructose 1,6-bisphosphatase (FBPase) is a critical step in the process of developing novel therapeutics against type-2 diabetes. Herein, we have successfully generated a library of allosteric inhibitors against FBPase as potential anti-diabetic drugs, of which, the lead compound 1b was identified through utilizing a virtual high-throughput screening (vHTS) system, which we have developed. The thiazole-based core structure was synthesized via the condensation of alpha-bromoketones with thioureas and substituents on the two aryl rings were varied. 4c was found to inhibit pig kidney FBPase approximately fivefold better than 1b. In addition, we have also identified 10b, a tight binding fragment, which can be use for fragment-based drug design purposes. (C) 2009 Elsevier Ltd. All rights reserved.
Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates
申请人:Kolbe Ludger
公开号:US20130039870A1
公开(公告)日:2013-02-14
Cosmetic or dermatological preparations having an effective content of one or more thiazoles of the general formula
US8920785B2
申请人:——
公开号:US8920785B2
公开(公告)日:2014-12-30
[DE] KOSMETISCHE ODER DERMATOLOGISCHE ZUBEREITUNGEN MIT EINEM GEHALT AN EINEM ODER MEHREREN THIAZOLDERIVATEN<br/>[EN] COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH A CONTENT OF ONE OR MORE THIAZOLE DERIVATIVES<br/>[FR] PRÉPARATIONS COSMÉTIQUES OU DERMATOLOGIQUES CONTENANT UN OU PLUSIEURS DÉRIVÉS DE THIAZOL
申请人:BEIERSDORF AG
公开号:WO2011117034A2
公开(公告)日:2011-09-29
Kosmetische oder dermatologische Zubereitungen mit einem wirksamen Gehalt an einem oder mehreren Thiazolen der allgemeinen Formel
A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase
作者:Sabrina Heng、Kimberly R. Gryncel、Evan R. Kantrowitz
DOI:10.1016/j.bmc.2009.04.030
日期:2009.6
The identification of a proper lead compound for fructose 1,6-bisphosphatase (FBPase) is a critical step in the process of developing novel therapeutics against type-2 diabetes. Herein, we have successfully generated a library of allosteric inhibitors against FBPase as potential anti-diabetic drugs, of which, the lead compound 1b was identified through utilizing a virtual high-throughput screening (vHTS) system, which we have developed. The thiazole-based core structure was synthesized via the condensation of alpha-bromoketones with thioureas and substituents on the two aryl rings were varied. 4c was found to inhibit pig kidney FBPase approximately fivefold better than 1b. In addition, we have also identified 10b, a tight binding fragment, which can be use for fragment-based drug design purposes. (C) 2009 Elsevier Ltd. All rights reserved.